ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Protalix Biotherapeutics, Inc." (PLX) Report Updated: Feb 27, 2017 | Print This Page

Get more stock ratings by Louis Navellier

"Protalix Biotherapeutics, Inc." (PLX)

Rating: Buy Volatility: Moderate
Total Grade: B Industry: Biotechnology
Competitors: CLCD,EXAS,EXEL,ARRY

Stock Analysis

Rating: Monthly View

A
B
C
D
F
February March April May June July August September October November December January

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up upgrade
service keys

"Protalix Biotherapeutics, Inc."© quotemedia

Company Profile